On the contrary, M2 cells are activated by type II cytokines such as IL-4, IL-10, IL-13, and transforming growth factor (TGF)-β, performing a pro-tumor immune response by producing factors as STAT3 [62], which contribute to tumor proliferation [60,63]. The gene discussed is IL13; the disease is neoplasm.